In an effort to improve clinical decision support through prescription drug price transparency, Epocrates, an Athenahealth firm, has expanded its cooperation with health IT provider ConnectiveRx. In an effort to improve medication adherence, Athenahealth has expanded a health IT cooperation for improved prescription drug price transparency.
- Cloud-based network: Patients on Athenahealth’s countrywide, cloud-based network could see lower out-of-pocket prescription expenditures as a result of the extended health IT relationship. According to research published in the Annals of Internal Medicine, 20 to 30 percent of prescriptions are never filled, and 50 percent of chronic disease drugs are not taken as prescribed.
- Lack of drugs: Lack of drug affordability and awareness of cost-saving options are two major barriers that contribute to low medication adherence. With the ConnectiveRx ScriptGuide program, providers will receive patient savings offers within the Athenahealth EHR after they write the prescription.
- New evolutions: “At Athenahealth, we constantly evolve our offerings to better support and engage healthcare professionals, aiming to deliver the personalized information they need to optimize patient care and outcomes,” Paul Brient, chief product officer at Athenahealth, said in a public statement.
- Agreement: Earlier last year, Epocrates and ConnectiveRx announced their agreement when Epocrates became the sole supplier of ConnectiveRx’s ScriptGuide patient savings messages. The clinical decision support system joins a slew of other health IT initiatives aimed at improving medication adherence.
- Partnership: “Through this partnership with ConnectiveRx, we look forward to providing additional value to our customers’ patients by addressing two of their biggest barriers: medication cost and non-adherence,” Brient continued. Last month, GoodRx announced a partnership with Surescripts to create a clinical decision support EHR integration that enhances prescription drug price transparency.